Affordable Access

Publisher Website

Serum Bilirubin and Disease Progression in Mild COPD.

Authors
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 1 Department of Medicine, Pulmonary Division, University of British Columbia, Vancouver, BC, Canada.
  • 2 UBC James Hogg Research Centre and the Institute for Heart and Lung Health, St. Paul's Hospital, Vancouver, BC, Canada; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Seoul, South Korea.
  • 3 Department of Pathology, University of British Columbia, Vancouver, BC, Canada.
  • 4 Department of Medicine, Pulmonary Division, University of British Columbia, Vancouver, BC, Canada; UBC James Hogg Research Centre and the Institute for Heart and Lung Health, St. Paul's Hospital, Vancouver, BC, Canada.
  • 5 Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA.
  • 6 Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
  • 7 Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN.
  • 8 Department of Medicine, Pulmonary Division, University of British Columbia, Vancouver, BC, Canada; UBC James Hogg Research Centre and the Institute for Heart and Lung Health, St. Paul's Hospital, Vancouver, BC, Canada. Electronic address: [email protected]
Type
Published Article
Journal
CHEST Journal
1931-3543
Publisher
Elsevier
Publication Date
Volume
148
Issue
1
Pages
169–175
Identifiers
DOI: 10.1378/chest.14-2150
PMID: 25539285
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments